Gallium Ga 68-DOTA-5G
Term · Oncology and biomedicine · MLC-T-ONC-013838
A radioconjugate composed of 5G, an agent targeting an as of yet undisclosed target, conjugated, via the bifunctional, macrocyclic chelating agent 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetra-acetic acid (DOTA), to the radioisotope gallium Ga 68, with potential use as a tracer for certain tumors during positron emission tomography (PET). Upon administration of the gallium Ga 68-DOTA-5G, the 5G moiety targets and binds to a specific target on tumor cells. Upon binding, the tumor cells can be detected during PET imaging.
| Identifier | MLC-T-ONC-013838 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | [68Ga]-DOTA-5G |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013838",
"term": "Gallium Ga 68-DOTA-5G",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate composed of 5G, an agent targeting an as of yet undisclosed target, conjugated, via the bifunctional, macrocyclic chelating agent 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetra-acetic acid (DOTA), to the radioisotope gallium Ga 68, with potential use as a tracer for certain tumors during positron emission tomography (PET). Upon administration of the gallium Ga 68-DOTA-5G, the 5G moiety targets and binds to a specific target on tumor cells. Upon binding, the tumor cells can be detected during PET imaging.",
"synonyms": [
"[68Ga]-DOTA-5G"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/gallium-ga-68-dota-5g/"
}
Record 7,717 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.